v3.25.2
Restructuring and Other Charges (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
IKENA ONCOLOGY INC    
Summary of Restructuring and Other Charges and Balance of Restructuring Liability Included in Accrued Employee Compensation
The Company’s restructuring and other charges and balance of its restructuring liability, which was included in accrued employee compensation, consisted of the following (in thousands):
 
    
Three Months Ended June 30, 2025
 
    
Employee
Related
Payments
    
Non-cash

Compensation
    
Asset
Impairments
    
Total
 
Accrued balance as of March 31, 2025
   $ 198      $ —       $ —       $ 198  
Expense
     309        —         —         309  
Payments
     (167      —         —         (167
Non-cash
     —         —         —         —   
  
 
 
    
 
 
    
 
 
    
 
 
 
Accrued balance as of June 30, 2025
   $ 340      $ —       $ —       $ 340  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Six Months Ended June 30, 2025
 
    
Employee
Related
Payments
    
Non-cash

Compensation
    
Asset
Impairments
    
Total
 
Accrued balance as of December 31, 2024
   $ —       $ —       $ —       $ —   
Expense
     1,568        176        —         1,744  
Payments
     (1,228      —         —         (1,228
Non-cash
     —         (176      —         (176
  
 
 
    
 
 
    
 
 
    
 
 
 
Accrued balance as of June 30, 2025
   $ 340      $ —       $ —       $ 340  
  
 
 
    
 
 
    
 
 
    
 
 
 
The Company’s Restructuring and other charges and balance of its Restructuring liability, which was included in accrued employee compensation, consisted of the following for the year ended December 31, 2024 (in thousands):
 
    
Year Ended December 31, 2024
 
    
Employee
Related
Payments
    
Non-cash

Compensation
    
Asset
Impairments
    
Total
 
Accrued balance at December 31, 2023
   $ —       $ —       $ —       $ —   
Expense
     3,414        263        742        4,419  
Payments
     (3,414      —         —         (3,414
Non-cash
     —         (263      (742      (1,005
  
 
 
    
 
 
    
 
 
    
 
 
 
Accrued balance at December 31, 2024
   $ —       $ —       $ —       $ —